Adoptive T-cell therapy. Cancer specific T-cells can be obtained by fragmentation and isolation of tumour infiltrating lymphocytes, or by genetically engineering<unk> s from peripheral blood. The<unk> s are activated and grown prior to transfusion into the recipient (tumour bearer).<unk>  (also called<unk> ular therapy,<unk>  transplantation, or cytotherapy) is a therapy in which viable<unk> s are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer<unk> s via<unk> -mediated immunity in the course of immunotherapy, or grafting stem<unk> s to regenerate diseased tissues.<unk>  originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human<unk> s could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation as has become common practice in treatment for patients that have compromised bone marrow after disease, infection, radiation or chemotherapy. In recent decades, however, stem<unk>  and<unk>  transplantation has gained significant interest by researchers as a potential new therapeutic strategy for a wide range of diseases, in particular for degenerative and immunogenic pathologies.
Cell therapy
Neural engineering
Neural tissue engineering
Tissue engineering
Stem-cell therapy
Antisense therapy
Cancer immunotherapy
Gene therapy